Literature DB >> 29959415

A non-myeloablative conditioning approach for long-term engraftment of human and mouse hematopoietic stem cells.

Wei Du1,2, Wei Liu3, Benjamin Mizukawa3, Xun Shang3, Jared Sipple3, Mark Wunderlich3, Hartmut Geiger3, Stella Davies3, James Mulloy3, Qishen Pang4, Yi Zheng5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29959415      PMCID： PMC6128741          DOI： 10.1038/s41375-018-0200-3

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

1.  Antibody targeting KIT as pretransplantation conditioning in immunocompetent mice.

Authors:  Xingkui Xue; Nancy K Pech; W Christopher Shelley; Edward F Srour; Mervin C Yoder; Mary C Dinauer
Journal:  Blood       Date:  2010-09-02       Impact factor: 22.113

2.  KIT blockade is sufficient for donor hematopoietic stem cell engraftment in Fanconi anemia mice.

Authors:  Shanmuganathan Chandrakasan; Rajeswari Jayavaradhan; John Ernst; Archana Shrestha; Anastacia Loberg; Phillip Dexheimer; Michael Jordan; Qishen Pang; Bruce Aronow; Punam Malik
Journal:  Blood       Date:  2016-12-20       Impact factor: 22.113

3.  Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment.

Authors:  Faiyaz Notta; Sergei Doulatov; Elisa Laurenti; Armando Poeppl; Igor Jurisica; John E Dick
Journal:  Science       Date:  2011-07-08       Impact factor: 47.728

4.  Correlation between pediatric donor characteristics and cell compositions in mixture allografts of combined G-CSF-mobilized PBSCs and bone marrow allografts.

Authors:  L-Q Cao; L Liu; L-P Xu; X-H Zhang; Y Wang; Q-Z Fan; Y-R Liu; K-Y Liu; X-J Huang; Y-J Chang
Journal:  Bone Marrow Transplant       Date:  2017-10-23       Impact factor: 5.483

Review 5.  Stem cell engraftment strategies.

Authors:  P J Quesenberry; F M Stewart; P Becker; L D'Hondt; A Frimberger; J F Lambert; G A Colvin; C Miller; C Heyes; M Abedi; M Dooner; J Carlson; J Reilly; C McAuliffe; K Stencel; K Ballen; R Emmons; P Doyle; S Zhong; H Wang; H Habibian
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

6.  Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation.

Authors:  M S Thakar; P Kurre; R Storb; M Kletzel; H Frangoul; M A Pulsipher; W Leisenring; M E D Flowers; B M Sandmaier; A Woolfrey; H-P Kiem
Journal:  Bone Marrow Transplant       Date:  2010-06-28       Impact factor: 5.483

7.  Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches.

Authors:  Agnieszka Czechowicz; Daniel Kraft; Irving L Weissman; Deepta Bhattacharya
Journal:  Science       Date:  2007-11-23       Impact factor: 47.728

8.  Rho GTPase Cdc42 coordinates hematopoietic stem cell quiescence and niche interaction in the bone marrow.

Authors:  Linda Yang; Lei Wang; Hartmut Geiger; Jose A Cancelas; Jun Mo; Yi Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-12       Impact factor: 11.205

9.  Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.

Authors:  Iskra Pusic; Shi Yuan Jiang; Scott Landua; Geoffrey L Uy; Michael P Rettig; Amanda F Cashen; Peter Westervelt; Ravi Vij; Camille N Abboud; Keith E Stockerl-Goldstein; Diane S Sempek; Angela L Smith; John F DiPersio
Journal:  Biol Blood Marrow Transplant       Date:  2008-09       Impact factor: 5.742

10.  Conditional deletion of STAT5 in adult mouse hematopoietic stem cells causes loss of quiescence and permits efficient nonablative stem cell replacement.

Authors:  Zhengqi Wang; Geqiang Li; William Tse; Kevin D Bunting
Journal:  Blood       Date:  2009-03-03       Impact factor: 22.113
View more
  5 in total

1.  Rational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilization.

Authors:  Wei Liu; Wei Du; Xun Shang; Lei Wang; Chris Evelyn; Maria Carolina Florian; Marnie A Ryan; Ahmad Rayes; Xueheng Zhao; Kenneth Setchell; Jarek Meller; Fukun Guo; Nicolas Nassar; Hartmut Geiger; Qishen Pang; Yi Zheng
Journal:  Leukemia       Date:  2018-09-25       Impact factor: 11.528

Review 2.  A concise review on factors influencing the hematopoietic stem cell transplantation main outcomes.

Authors:  Mohammad Rafiee; Mohammad Abbasi; Hassan Rafieemehr; Amin Mirzaeian; Mohieddin Barzegar; Vahid Amiri; Shaghayegh Shahsavan; Mohammad Hossein Mohammadi
Journal:  Health Sci Rep       Date:  2021-05-07

3.  Quinacrine-CASIN combination overcomes chemoresistance in human acute lymphoid leukemia.

Authors:  Limei Wu; Srinivas Chatla; Qiqi Lin; Fabliha Ahmed Chowdhury; Werner Geldenhuys; Wei Du
Journal:  Nat Commun       Date:  2021-11-26       Impact factor: 14.919

4.  Inhibition of Cdc42 activity extends lifespan and decreases circulating inflammatory cytokines in aged female C57BL/6 mice.

Authors:  Maria Carolina Florian; Hanna Leins; Michael Gobs; Yang Han; Gina Marka; Karin Soller; Angelika Vollmer; Vadim Sakk; Kalpana J Nattamai; Ahmad Rayes; Xueheng Zhao; Kenneth Setchell; Medhanie Mulaw; Wolfgang Wagner; Yi Zheng; Hartmut Geiger
Journal:  Aging Cell       Date:  2020-08-04       Impact factor: 9.304

5.  Aging of human hematopoietic stem cells is linked to changes in Cdc42 activity.

Authors:  Amanda Amoah; Anja Keller; Ramiz Emini; Markus Hoenicka; Andreas Liebold; Angelika Vollmer; Karina Eiwen; Karin Soller; Vadim Sakk; Yi Zheng; Maria Carolina Florian; Hartmut Geiger
Journal:  Haematologica       Date:  2022-02-01       Impact factor: 9.941
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.